The global oncolytic virus therapies market size was valued at USD 270.28 Million in 2024 and is expected to grow from USD 341.37 Million in 2025 to reach USD 2210.28 Million by 2033, exhibiting a CAGR of 26.30% during the forecast period (2025–2033). The market is expected to witness high growth, attributed to the increasing burden of cancer coupled with the soaring demand for gene therapies and research methods.

Market Scope and Research Methodology

This report includes a multi-level regional assessment spanning global, regional, and country-specific markets. The analysis highlights market penetration, regional market leadership, and the strategic approaches adopted by prominent companies. A detailed SWOT analysis identifies the strengths, weaknesses, opportunities, and challenges within the market.

The primary goal of the Oncolytic Virus Therapies Market Report is to provide clear insights into market behavior, emerging trends, and the factors influencing market performance. The study evaluates market structure, segmentation, and forecasted market size while examining growth drivers, industry barriers, and opportunities stemming from technological progress, regulatory frameworks, cost efficiencies, and evolving consumer needs.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart): https://straitsresearch.com/report/oncolytic-virus-therapies-market/request-sample

Regional Insights

The report presents an in-depth regional assessment of the Oncolytic Virus Therapies Market across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each region is analyzed based on key parameters such as market size, growth rate, trade activities, and overall industry development. This segmentation supports a deeper understanding of the competitive dynamics and market potential within each geographical area.

Market Segmentation

1. By Commercialized Therapies
   1. Imlygic
   2. Oncorine
   3. RIGVIR
2. By Pipeline Therapies
   1. Phase I
   2. Phase II
   3. Phase III
   4. Phase IV
3. By Type of Virus
   1. Genetically Engineered Oncolytic Virus
      1. Herpes Simplex Virus (HSV)
      2. Adenovirus
      3. Vaccinia Virus
      4. Oncolytic Wild-Type Virus
   2. Reovirus (Respiratory Enteric Orphan Virus)
      1. Newcastle Disease Virus (NDV)
      2. Vesicolar Stomatitis Virus (VSV)
4. By Application
   1. Solid Tumor
      1. Breast Cancer
      2. Prostate Cancer
      3. Lung Cancer
      4. Glioblastoma
      5. Melanoma
      6. Other Applications
   2. Hematological Malignancies
      1. Lymphoma
      2. Leukemia
      3. Myeloma

Key Market Players

1. Amgen Inc
2. DAIICHI SANKYO COMPANY LIMITED
3. DNAtrix
4. Genelux
5. Oncolytics Biotech Inc
6. PsiOxus Therapeutics
7. RIGVIR Ltd
8. Shanghai Sunway Biotech Co. Ltd.
9. SillaJen Inc
10. Sorrento Therapeutics Inc
11. Takara Bio Inc
12. Transgene SA
13. VCNBiosciences
14. ViroCure
15. Viralytics Ltd.(Merck & Co., Inc.) 

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart): https://straitsresearch.com/report/oncolytic-virus-therapies-market/request-sample

Key Questions Addressed

• What is Oncolytic Virus Therapies Market?
• What was the market size of the Oncolytic Virus Therapies Market in 2024?
• What CAGR is expected for the market during the forecast period?
• Which factors are expected to drive market growth?
• What are the major segments of the market?
• Which strategies are companies adopting to strengthen their market presence?
• What emerging applications and trends are shaping the industry?
• Who are the key players in the Oncolytic Virus Therapies Market?
• What are the portfolios and competencies of leading market participants?

About Us

For over a decade, Straits Research has been a trusted partner to more than 2,590 small and large enterprises, empowering senior leaders and decision-makers with actionable intelligence to navigate complex markets. Our structured syndicate reports, published year-round, cover critical sectors such as chemicals, materials, food and beverage, healthcare, pharmaceuticals, automotive, technology, aerospace, and defense. Combined with our custom research tailored to client-specific needs, we deliver insights that drive business progress and informed decision-making.